A new study, published in the World Journal of Clinical Oncology, reveals that psilocybin may significantly improve the quality of life for patients with advanced cancer.

Dried psilocybin mushrooms. (Photo credit: Kevin J. Beaty/Denverite).
The study, conducted by researchers from the University of Michigan and the University of New Mexico and published online by the US National Library of Medicine, highlights the compound’s potential in alleviating symptoms of anxiety and depression among this patient group.
The meta-analysis included seven studies with a total of 132 participants, assessing the effects of psilocybin-assisted therapy.
Continue reading